Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil and C2 domain-containing protein 1B (CC2D1B) is a protein found in myelinating glial cells of the central and peripheral nervous system (including Schwann cells and oligodendrocytes). It contains four DM14 domains that mediate interaction with the ESCRT-III endosomal sorting machinery (notably CHMP7 and CHMP4B), and a C-terminal C2 domain enabling membrane lipid binding. CC2D1B is involved in regulating the reformation of the nuclear envelope after mitosis by coordinating timely ESCRT-III recruitment and membrane remodeling, ensuring nuclear integrity following cell division. It also modulates gene transcription, including repression of the serotonin 1A receptor in neurons. Unlike its close homolog CC2D1A, which is linked to intellectual disability and autism, CC2D1B’s deficiency leads to defects in myelination and can impair memory in animal models. There are no known interacting drugs, biomarker uses, or direct links to major human diseases as of current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil and C2 domain-containing protein 1B (CC2D1B).